Retraction: Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity (PLoS ONE (2012) 7: 5 (e36909) DOI: 10.1371/journal.pone.0036909);Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Chiantore, Maria V ^a   Vannucchi, Serena ^a   Accardi, Rosita ^b   Tommasino, Massimo ^b   Percario, Zulema A ^c   Vaccari, Gabriele ^a   Affabris, Elisabetta ^c   Fiorucci, Gianna ^a,d   Romeo, Giovanna ^a,e  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c ROMA TRE UNIVERSITY   (Italy)

^d CNR   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; DELTA NP73 PROTEIN; MESSENGER RNA; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN E6; PROTEIN E7; PROTEIN INHIBITOR; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL AGING; CELL CYCLE S PHASE; CELL NUCLEUS INCLUSION BODY; CELL VIABILITY; CELLULAR SENESCENCE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 38; KERATINOCYTE; NONHUMAN; PML GENE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; SENESCENCE; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; VIRUS CELL TRANSFORMATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 84861205347     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0214341     Document Type: Erratum

References (52)

1. Vannucchi S, Chiantore MV, Mangino G, Percario ZA, Affabris E, et al. (2007) Perspectives in biomolecular therapeutic intervention in cancer: from the early to the new strategies with type I interferons. Curr Med Chem 14: 667-79.
2. Bekisz J, Baron S, Balinsky C, Morrow A, Zoon KC, (2010) Antiproliferative Properties of Type I and Type II Interferon. Pharmaceuticals (Basel) 3: 994-1015.
3. Rebbaa A, Zheng X, Chou PM, Mirkin BL, (2003) Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22: 2805-11.
4. Kim R, Emi M, Tanabe K, Uchida Y, Arihiro K, (2006) The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment. Eur J Surg Oncol 32: 269-77.
5. Chiantore MV, Vannucchi S, Mangino G, Percario ZA, Affabris E, et al. (2009) Senescence and cell death pathways and their role in cancer therapeutic outcome. Curr Med Chem 16: 287-300.
6. Campisi J, (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513-22.
7. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci Usa 92: 9363-67.
8. Condemine W, Takahashi Y, Le Bras M, de Thé H, (2007) A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J Cell Science 120: 3219-27.
9. Geoffroy MC, Chelbi-Alix MK, (2011) Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res 31: 145-58.
10. Shay JW, Pereira-Smith OM, Wright WE, (1991) A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196: 33-9.
11. Boehm JS, Hahn WC, (2005) Understanding transformation: progress and gaps. Curr Opin Genet Dev 15: 13-7.
12. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, et al. (2007) Restoration of p53 function leads to tumour regression in vivo. Nature 445: 661-65.
13. Xue W, Zender L, Miething C, Dickins RA, Hernando E, et al. (2007) Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinoma. Nature 445: 656-60.
14. Yoon IK, Kim HK, Kim YK, Song IH, Kim W, et al. (2004) Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Exp Gerontol 39: 1369-78.
15. Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, et al. (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11: 2565-73.
16. Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, Ferbeyre G, (2006) DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell 17: 1583-92.
17. Pammer J, Reinisch C, Birner P, Pogoda K, Sturzl M, et al. (2006) Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continous stimulation. Lab Invest 86: 997-1007.
18. Zur Hausen H, (2009) Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384: 260-65.
19. Hebner CM, Laimins LA, (2006) Human papillomaviruses: basic mechanism of pathogenesis and oncogenicity. Rev Med Virol 16: 83-97.
20. Caldeira S, Zehbe I, Accardi R, Malanche I, Dong W, et al. (2003) The E6 and E7 proteins of cutaneous human papillomavirus type 38 display transforming properties. J Virol 77: 2195-206.
21. Accardi R, Dong W, Smet A, Cui R, Hautefeuille A, et al. (2006) Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep 7: 334-40.
22. Buhlmann S, Pützer BM, (2008) DNp73 a matter of cancer: mechanisms and clinical implications. Biochem Biophys Acta 1785: 207-16.
23. Testoni B, Schinzari V, Guerrieri F, Gerbal-Chaloin S, Blandino G, et al. (2011) p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor. Oncogene 30: 2670-8.
24. Vannucchi S, Percario ZA, Chiantore MV, Matarrese P, Chelbi-Alix MK, et al. (2000) Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells. Oncogene 19: 5041-53.
25. Bourdeau V, Baudry D, Ferbeyre G, (2009) PML links aberrant cytokine signaling and oncogenic stress to cellular senescence. Frontiers in Bioscience 14: 475-85.
26. Dai C, Gu W, (2010) p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 16: 528-36.
27. Kim KS, Kang KW, Seu YB, Baek SH, Kim JR, (2009) Interferon-γ induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech of ageing and develop 130: 179-88.
28. Johung K, Goodwin EC, DiMaio D, (2007) Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 81: 2102-16.
29. Sima N, Wang S, Wang W, Kong D, Xu Q, et al. (2007) Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Gynecol Oncol 106: 299-304.
30. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, et al. (2006) Human papillomavirus infection and incidence of squamous cell and basal cell carcinoma of the skin. J Natl Cancer Inst 98: 389-95.
31. Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA, (2008) E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol 82: 10408-17.
32. Struijk L, van der Meijden E, Kazem S, ter Schegget J, de Gruijl FR, et al. (2008) Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes. J Gen Virol 89: 2303-14.
33. Giampieri S, Garcia-Escudero R, Green J, Storey A, (2004) Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br. J. Cancer 90: 2203-09.
34. Giampieri S, Garcia-Escudero R, Green J, Storey A, (2004) Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation. Oncogene 23: 5864-70.
35. Iftner T, Elbel M, Schopp B, Hiller T, Loizou JI, et al. (2002) Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 21: 4741-48.
36. Pfefferle R, Marcuzzi GP, Akgul B, Kasper HU, Schulze F, et al. (2008) The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J Inv Dermatol 128: 2310-15.
37. Michel A, Kopp-Schneider A, Zentgraf H, Gruber AD, de Villiers EM, (2006) E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKN-hr1 transgenic mice. J Virol 80: 11153-64.
38. Gabet AS, Accardi R, Bellopede A, Popp S, Boukamp P, et al. (2008) Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. FASEB J 22: 622-32.
39. Vannucchi S, Chiantore MV, Fiorucci G, Percario ZA, Leone S, et al. (2005) Trail is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells. Oncogene 7: 2536-46.
40. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, et al. (1999) PML is critical for ND 10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol 147: 221-34.
41. Webley K, Bond JA, Jones CJ, Blaydes JP, Craig A, et al. (2000) Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol. Cell Biol 20: 2803-08.
42. Ferbeyre G, de Stanchina E, Querido E, Baptist N, Prives C, et al. (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14: 2015-27.
43. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, et al. (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21: 2383-96.
44. Moller A, Sirma H, Hofmann TG, Rueffer S, Klimeczak E, et al. (2003) PML is requires for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosporylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res 63: 4310-14.
45. Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, et al. (2002) Regulation of p53 activity by ist interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4: 1-10.
46. de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, et al. (2004) PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13: 523-35.
47. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-42.
48. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G, (2007) The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 21: 43-8.
49. Toledo LI, Murga M, Gutierrez-Martinez P, Soria R, Fernandez-Capetillo O, (2008) ATR signaling can drive cells into senescence in the absence of DNA breaks. Genes De. 22: 297-302.
50. Hebner C, Beglin M, Laimins LA, (2007) Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation. J Virol 81: 12740-47.
51. Allison SJ, Jiang M, Milner J, (2009) Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging 1: 316-27.
52. Zhang G, Sun L, Li Z, Si L, Song T, et al. (2009) HPV-16E6 can induce multiple site phosporylation of p53. Oncol Rep 21: 371-77.